Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

ABPI's London offices

ABPI and BIA move in together

May 16, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA

The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …
News

It’s time we redesigned the clinical trial

May 16, 2011 Research and Development clinical trials, randomised controlled trials

Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …
Feature

Takeda denies $12bn Nycomed takeover reports

May 13, 2011 Research and Development, Sales and Marketing Nycomed, Takeda

Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …
News
European Parliament

EMA under fire from European Parliament

May 13, 2011 Medical Communications, Research and Development, Sales and Marketing EMA, European Parliament, MEPs

The EMA has been hit by a barrage of criticism from the European Parliament over conflicts of interest and the …
News
GlaxoSmithKline

GSK and AZ collaborate on translational research centre

May 12, 2011 Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research

The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …
News

Government wrong to push for Avastin in eye disease, says charity

May 12, 2011 Research and Development, Sales and Marketing Lucentis, RNIB, avastin, wet AMD

The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …
News

AZ signs targeted colon cancer drug collaboration

May 11, 2011 Research and Development AstraZeneca, colorectal cancer, personalised medicine

AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …
News

Drug regulators protect profits over patients, new study finds

May 11, 2011 Research and Development Bad Science, Vioxx, regulatory affairs

Medicine regulators are protecting drug company profits over the welfare of patients by withholding trial data. That’s the verdict of …
News

Verdict on AMT’s gene therapy expected soon

May 11, 2011 Research and Development, Sales and Marketing AMT, Amsterdam Molecular Therapeutics, gene therapy, genes

Amsterdam Molecular Therapeutics says it will shortly receive the regulatory verdict on its gene therapy Glybera. Glybera (alipogene tiparvovec) is …
News

Service Insight: Clinical trials – managing route to market

May 11, 2011 Research and Development Service Insight, Talking Point, research and development

SERVICE INSIGHT Clinical trials are notoriously difficult to manage and often fraught with problems, as they can involve many clinical …
Feature

Pfizer drops early-stage asthma candidate

May 11, 2011 Research and Development Pfizer, Rigel, asthma

Pfizer has returned the rights to a phase I asthma candidate to Rigel Pharmaceuticals. San Francisco-based Rigel says Pfizer is …
News
Sanofi's new logo

Sanofi name change sees Aventis dropped

May 9, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis

Sanofi-Aventis will now just be known as Sanofi after the French pharma company’s shareholders agreed to change its name. Following …
News

Thomas Lingelbach appointed chief executive of Intercell

May 5, 2011 Research and Development appointment, research and development

Vienna-based biotech Intercell has appointed Thomas Lingelbach as chief executive with effect from 10 May. He has more than twenty …
Appointment

INC Research to acquire Kendle

May 5, 2011 Research and Development INC Research, Kendle, cros

Two contract research organisations INC Research and Kendle International are to merge to create a new major player in the …
News

Sanofi signs malaria research alliance

May 5, 2011 Research and Development Medicines for Malaria Venture, Sanofi-Aventis, malaria

Sanofi-Aventis has signed a research deal with the Medicines for Malaria Venture charity. They will work together to identify, characterise …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026